Physician profile
Amber D Rice
NPI 1659718260
$36,986.51
in general payments reported to CMS, 2019-2025
5 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $800 · 2023: $237 · 2024: $304 · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Honoraria: $600 · Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,000.00 |
| Honoraria | $600.00 |
| Food and Beverage | $586.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Medical Corporation | $35,800.00 | 2021-2025 | Defibrillator |
| Purdue Pharma L.P. | $600.00 | 2025 | Nalmefene Hydrochloride |
| Stryker Corporation | $419.36 | 2023-2024 | Lifepak 15 Monitor/Defibrillator |
| Bioxcel Therapeutics, INC. | $121.95 | 2023 | Igalmi |
| Grifols USA, LLC | $45.20 | 2025 | Hyperrab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.